Comprehensive resource platform

  1. New progress in luminescence: The number of manufacturers is gradually increasing The addition of new brands is bound to accelerate the clinical acceptance of luminescence  detection cytokines . Differentiation began to emerge in the items From the perspective of the manufacturers that have been certified so far, the main items cover  IL-1β, IL-2, IL-2R, IL-4, IL-5, IL-6, IL-8, IL-10, TNF-α, IL-17, IFN-α, IFN-γ , etc. 2. How to promote the market？ Clinical clarity is required As a manufacturer, the product line can be invested in more academic activities with sufficient funds, increase academic influence, and expand brand awareness; If the funds are not rich enough, you can use the medical manager to increase the pre-sales publicity, and every clinical exchange is actually to tell the insiders the value of the project.   The promotional content focuses on which departments can be opened, what are the items that need to be focused on by different diseases/de...